Vimarsana
Biggest News Aggregation in the World

Comprehensive Neuromuscular Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comprehensive Neuromuscular Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comprehensive Neuromuscular Program Today - Breaking & Trending Today

REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial - Vimarsana News

REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial

Published: February 29, 2024

Company to host webcast on Tuesday, March 5, 2024 at 8:30 a.m. ESTInterim clinical data will be presented by Aravindhan Veerapandiyan, M.D., primary investigator of the AFFINITY DUCHENNE trial, at...

Source: marketscreener.com
Related Topics:
United StatesAravindhan VeerapandiyanDana CormackChris BrinzeyMuscular Dystrophy AssociationCertified Duchenne Care CenterNeuromuscular ProgramCorporate CommunicationsScientific ConferenceInterim Clinical DataDystrophy AssociationClinical TrialComprehensive Neuromuscular ProgramDuchenne Care CenterMuscular Dystrophy Association Care CenterArkansas Children
REGENXBIO Announces Phase I/II Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy, is Active and Recruiting Patients - Vimarsana News

REGENXBIO Announces Phase I/II Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy, is Active and Recruiting Patients

Published: January 23, 2023

- Company has initiated Phase I/II AFFINITY DUCHENNE™ trial of RGX-202 - Company also enrolling newly active observational screening study, AFFINITY BEYOND,...

Source: prnewswire.com
Related Topics:
United StatesDana CormackAravindhan VeerapandiyanChris BrinzeyTechnology PlatformTechnology Platform LicenseesExchange CommissionCertified Duchenne Care CenterCorporate CommunicationsSecurities ExchangeManufacturing Innovation CenterNeuromuscular ProgramInnovation CenterChief Executive OfficerComprehensive Neuromuscular ProgramDuchenne Care CenterMuscular Dystrophy Association Care CenterArkansas ChildrenNorth Star Ambulatory AssessmentObservational StudyPlatform LicenseesSecurities ActSecurities Exchange ActFinancial ConditionRegenxbio Inc